Alan S Gamis MD MPH
Pediatric Oncologist, Professor of Pediatrics
Join to View Full Profile
2401 Gillham Rd# ChildrenKansas City, MO 64108
Phone+1 816-302-6808
Fax+1 816-302-9894
Dr. Gamis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Gamis is a Pediatric Hematologist/Oncologist based in Kansas City, MO, specializing in myeloid malignancies, lymphoma, and leukemia, particularly acute lymphoblastic and myeloblastic leukemia. He completed his education at the University of Illinois College of Medicine (1984) followed by an internship, residency, and fellowship in pediatric hematology/oncology. Since 1991, he has practiced at Children’s Mercy Hospital and has held a professorship at the University of Missouri Kansas City School of Medicine since 2008. His research has been published in notable journals such as Blood Advances and Nature Communications. He has been involved in multiple clinical trials concerning acute myeloid leukemia and has received several honors, including being named a Regional Top Doctor by Castle Connolly.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1988 - 1991
Children’s Mercy HospitalResidency, Pediatrics, 1985 - 1988
University of Missouri-Kansas City School of MedicineInternship, Internal Medicine, 1984 - 1985
University of Illinois College of MedicineClass of 1984
Certifications & Licensure
MO State Medical License 1986 - 2027
KS State Medical License 2014 - 2026
MN State Medical License 1988 - 1991
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome Start of enrollment: 1999 Jun 01
- Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Publications & Presentations
PubMed
- Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.Nastassja Keora Scheidegger, Constanze Schneider, Gabriela Alexe, Yi-Cheng Wang, Todd A Alonzo
Blood Advances. 2026-05-05 - Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohort.Lisa A Lansdon, Byunggil Yoo, Ayse Keskus, Irina Pushel, Chengpeng Bi
NPJ Genomic Medicine. 2026-04-09 - HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report...Vasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, Alan S Gamis, Richard Aplenc
Haematologica. 2026-03-26
Abstracts/Posters
- Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report ...Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a ChildrenÍs Onc...Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Response to Sorafenib in FLT3/ITD AML Is Depedent on Co-Occurring Mutational ProfileAlan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Children’s Mercy Kansas City Tackles the Unique Complexity of Pediatric CancerMarch 10th, 2023
Doctors, Parents Frustrated over Critical Cancer Drug ShortageOctober 18th, 2019
Shortage of Chemotherapy Drug Affecting Dozens of Kids with Cancer in KC MetroOctober 18th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
